Access Issues Shortages and insurance barriers create major obstacles for patients needing GLP-1 medications
When asked if Lilly would consider seeking a priority review voucher, which can cut the Food and Drug Administration's decision time for a new drug application to six months from the standard 10, Custer said "all options are on the table." Top-line data from orforgliprons earlier late-stage study in overweight or obese adults without diabetes showed 12.4% average weight loss
Ideal for Multiple Areas: Suitable for areas like the chin, arms, thighs, and abdomen, offering flexible options for targeted fat reduction
Broadly, studies suggest GLP-1RAs exert their neuroprotective effects in the retina by mediating reduced glutamate excitotoxicity, decreased neuroinflammation, prevention of retinal ganglion cell (RGC) loss, promotion of vascular integrity, promotion of an anti-oxidative environment, and maintenance of glial cells (i.e